Patent · US Active

Enhancer for antibody to lymphocytic tumors

US7790152B2 · kind B2 · utility

1Cited by

6References

8Claims

0Family size

Assignee

CHUGAI SEIYAKU KABUSHIKI KAISHA · JP

Inventors

Masaaki Kosaka · Tokushima, JP
Yasuo Koishihara · Gotenba, JP

Key dates

Filing date	May 2, 2003
Grant date	Sep 7, 2010
Priority date	—
Expiry date	Jun 26, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An enhancer, for treatment of lymphocytic tumors, of an antibody that specifically binds to protein having the amino acid sequence as set forth in SEQ ID NO: 1 and that has a cytotoxic activity, said enhancer comprising a biological response modifier as an active ingredient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.